In Oct 2016, a class-action lawsuit was filed against Sanmedica International for allegedly falsely advertising that Sero Vital-hgh provides anti-aging benefits. Specifically, the complaint alleges that the company markets the pill as, among other things, having the ability to “turn back time” in the human aging process and increase Human Growth Hormone (HGH) levels in the body by 682% when, in reality, such claims are false. (Martin et al v. Sanmedica International, LLC and Does 1-10, Case No. 16-cv-7794, C. D. CA.)
For more information about other class-action lawsuits regarding anti-aging products and TINA.org’s coverage of them, click here.
In May 2018, a class-action lawsuit was filed against SanMedica International for allegedly falsely advertising the Human Growth Hormone (HGH) supplement SeroVital-hgh. Specifically, plaintiffs claim that SanMedica falsely markets the…
April 2017: The Ninth Circuit Court of Appeals affirmed the district court’s decision to dismiss this lawsuit. March 2015: The plaintiffs appealed the district court’s decision to dismiss the lawsuit.…
The magic of Christmas makes the impossible, possible 😉🎁 #AirNZXmas
Sneaker company modifies sponsored social media post following TINA.org inquiry.
Class-action settlements that left consumers behind this year.
“Sitewide” sale didn’t include all items for sale on the site.
Asa Hiken, Adage